De novo design of D-peptide ligands: Application to influenza virus hemagglutinin
- PMID: 40577121
- PMCID: PMC12232713
- DOI: 10.1073/pnas.2426554122
De novo design of D-peptide ligands: Application to influenza virus hemagglutinin
Abstract
D-peptides hold great promise as therapeutics by alleviating the challenges of metabolic stability and immunogenicity in L-peptides. However, current D-peptide discovery methods are severely limited by specific size, structure, and the chemical synthesizability of their protein targets. Here, we describe a computational method for de novo design of D-peptides that bind to an epitope of interest on the target protein using Rosetta's hotspot-centric approach. The approach comprises identifying hotspot sidechains in a functional protein-protein interaction and grafting these side chains onto much smaller structured peptide scaffolds of opposite chirality. The approach enables more facile design of D-peptides and its applicability is demonstrated by design of D-peptidic binders of influenza A virus hemagglutinin, resulting in identification of multiple D-peptide lead series. The X-ray structure of one of the leads at 2.38 Å resolution verifies the validity of the approach. This method should be generally applicable to targets with detailed structural information, independent of molecular size, and accelerate development of stable, peptide-based therapeutics.
Keywords: D-peptide; X-ray crystallography; computational design; hemagglutinin; influenza.
Conflict of interest statement
Competing interests statement:A patent application related to this work has been filed by some of the authors (J.J., D.B., R.V., and R.H.E.F) (application number PCT/EP2016/075916; publication number WO 2017/072222 Al). NIH grants R56 AI117675 and R56 AI127371.
References
-
- Lau J. L., Dunn M. K., Therapeutic peptides: Historical perspectives, current development trends, and future directions. Bioorg. Med. Chem. 26, 2700–2707 (2018). - PubMed
-
- Fosgerau K., Hoffmann T., Peptide therapeutics: Current status and future directions. Drug Discov. Today 20, 122–128 (2015). - PubMed
-
- Vlieghe P., Lisowski V., Martinez J., Khrestchatisky M., Synthetic therapeutic peptides: Science and market. Drug Discov. Today 15, 40–56 (2010). - PubMed
-
- Hamamoto K., Kida Y., Zhang Y., Shimizu T., Kuwano K., Antimicrobial activity and stability to proteolysis of small linear cationic peptides with D-amino acid substitutions. Microbiol. Immunol. 46, 741–749 (2002). - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources